pharmacare
Discussion and Debate
Health Canada and the Pharmaceutical Industry: A Preliminary Analysis of the Historical Relationship
Joel Lexchin
Value for Money
Piloting an Outpatient Policy for Funding Drugs and Their Administration in Rheumatology
Bernadette Chevalier, Christy Simpson, Heather Hemming, Anne Hiltz, Randi Monroe and Victoria Sulliv...
Data Matters
Cost-Control Mechanisms in Canadian Private Drug Plans
Jillian Kratzer, Kimberlyn McGrail, Erin Strumpf and Michael R. Law
Research Paper
Product Listing Agreements (PLAs): A New Tool for Reaching Quebec's Pharmaceutical Policy Objectives?
Mélanie Bourassa Forcier and François Noël
Research Paper
Coalition Priorité Cancer and the Pharmaceutical Industry in Québec: Conflicts of Interest in the Reimbursement of Expensive Cancer Drugs?
David Hughes and Bryn Williams-Jones
Managing Information
Drug Information Systems: Evolution of Benefits with System Maturity
Valerie Leung, Simon Hagens and Jennifer Zelmer
Research Paper
Use of Product Listing Agreements by Canadian Provincial Drug Benefit Plans
Steven G. Morgan, Melissa K. Friesen, Paige A. Thomson and Jamie R. Daw